H. L. Clark, A. Jhingran, Y. Sun, C. Vareechon, S. De-jesus-carrion et al., , p.431

J. A. Calera, T. M. Hohl, and E. Pearlman, Zinc and Manganese Chelation by Neutrophil 432 S100A8/A9 (Calprotectin) Limits Extracellular Aspergillus fumigatus Hyphal Growth and 433 Corneal Infection, J Immunol, vol.196, p.15, 2016.

C. Clavaud, A. Beauvais, L. Barbin, H. Munier-lehmann, and J. P. Latge, The 435 composition of the culture medium influences the beta-1,3-glucan metabolism of Aspergillus 436 fumigatus and the antifungal activity of inhibitors of beta-1,3-glucan synthesis, Agents Chemother, vol.437, p.16, 2012.

A. Crawford and D. Wilson, Essential metals at the host-pathogen interface: 439 nutritional immunity and micronutrient assimilation by human fungal pathogens. FEMS Yeast 440 Res 15, vol.441, p.17, 2015.

S. Finnegan and S. L. , EDTA: An Antimicrobial and Antibiofilm Agent for Use 442 in Wound Care, Adv Wound Care, vol.4, p.18, 2015.

C. Galiger, M. Brock, G. Jouvion, A. Savers, M. Parlato et al., 444 Assessment of efficacy of antifungals against Aspergillus fumigatus: value of real-time 445 bioluminescence imaging, Antimicrob Agents Chemother, vol.57, p.19, 2013.

R. Hachem, P. Bahna, H. Hanna, L. C. Stephens, and I. Raad, EDTA as an adjunct 447 antifungal agent for invasive pulmonary aspergillosis in a rodent model, Antimicrobial Agents, vol.448, pp.1823-1827, 2006.

Z. Halime, M. Lachkar, L. Toupet, A. G. Coutsolelos, and B. Boitrel, Coordination and 450 structural studies of crowned-porphyrins, vol.451, pp.3684-3693, 2007.

M. F. Hibert, French/European academic compound library initiative, Drug Discov, vol.452, p.22, 2009.

M. I. Hood and E. P. Skaar, Nutritional immunity: transition metals at the pathogen454 host interface, Nat Rev Microbiol, vol.10, p.23, 2012.

C. S. Kang, S. Ren, X. Sun, and H. S. Chong, Theranostic Polyaminocarboxylate456, 2016.

. Cyanine-transferrin, Conjugate for Anticancer Therapy and Near-Infrared Optical Imaging, ChemMedChem, vol.457, p.24

A. Kicic, A. C. Chua, and E. Baker, Effect of iron chelators on proliferation and iron 459 uptake in hepatoma cells, Cancer, vol.92, p.25, 2001.

S. K. Krishnasamy, V. Namasivayam, S. Mathew, R. S. Eakambaram, and I. A. Ibrahim,

S. Natarajan and . Palaniappan, Design, Synthesis, and Characterization of Some 462, 2016.

, Hybridized Pyrazolone Pharmacophore Analogs against Mycobacterium tuberculosis, Archiv 463 Der Pharmazie, vol.349, p.26

P. Laskaris, A. Atrouni, J. A. Calera, C. Enfert, H. Munier-lehmann et al.,

O. Latge and . Ibrahim-granet, Administration of Zinc Chelators Improves Survival of 466, 2016.

, Mice Infected with Aspergillus fumigatus both in Monotherapy and in Combination with 467 Caspofungin, Antimicrob Agents Chemother, vol.60, p.27

C. Y. Li, X. B. Zhang, Y. Y. Dong, Q. J. Ma, Z. X. Han et al., 469 A porphyrin derivative containing 2-(oxymethyl)pyridine units showing unexpected 470 ratiometric fluorescent recognition of Zn2+ with high selectivity, Anal Chim Acta, vol.616, p.28, 2008.

P. F. Liguori, A. Valentini, M. Palma, A. Bellusci, S. Bernardini et al.,

F. Pettinari, A. Marchetti, D. Crispini, and . Pucci, Non-classical anticancer agents: 473 synthesis and biological evaluation of zinc(II) heteroleptic complexes, Dalton Transactions, vol.474, p.29, 2010.

C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feeney, Experimental and 476 computational approaches to estimate solubility and permeability in drug discovery and 477 development settings, Adv Drug Deliv Rev, vol.46, p.30, 2001.

A. Mayr, M. Aigner, and C. Lass, Caspofungin: when and how? The 479 microbiologist's view, Mycoses, vol.55, p.31, 2012.

M. C. Monteiro, M. De-la-cruz, J. Cantizani, C. Moreno, J. R. Tormo et al., , p.481

F. Lucas, V. Asensio, A. A. Valiante, J. P. Brakhage, O. Latge et al., Most 570 treated mice (6/10) displayed minimal to mild inflammatory lesions, characterized by 571 perivascular lymphocyte and plasma cell infiltrates (black arrowheads) (GH), with no fungi 572 invading the parenchyma (I), 2012.